Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses

There are currently four countries and one local region in Europe that use PAP in their newborn screening programme. The first country to employ PAP at a national level was the Netherlands, which started using IRT/PAP/DNA/EGA in 2011. Germany followed in 2016 with a slightly different IRT/PAP/DNA st...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerburg, Olaf, Hammermann, Jutta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422993/
https://www.ncbi.nlm.nih.gov/pubmed/33073025
http://dx.doi.org/10.3390/ijns6020028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422993/
https://www.ncbi.nlm.nih.gov/pubmed/33073025
http://dx.doi.org/10.3390/ijns6020028

Ejemplares similares